Recent Evolution of Renal Replacement Therapy in the Critically Ill Patient

Overview

Journal Crit Care

Specialty Critical Care

Date 2006 Mar 18

PMID 16542480

Citations 6

Authors

Claudio Ronco

Affiliations

Soon will be listed here.

Abstract

The epidemiology of severe acute renal failure has dramatically changed in the past decade. Its leading cause is sepsis and the syndrome develops mostly in the intensive care unit as part of multiple organ dysfunction syndrome. After the significant improvements obtained from the mid 1970s to the mid 1990s, the past decade has seen a dramatic evolution in technology leading to new machines and new techniques for renal and multiple organ support. Extracorporeal therapies are now performed using adequate treatment doses, which have resulted in improved survival in the general population. At the same time, patients with sepsis seem to benefit from the use of increased doses, as in the case of high-volume hemofiltration or of increased membrane permeability and sorbents as in the case of continuous plasmafiltration adsorption. The humoral theory of sepsis and the peak concentration hypothesis have spurred a significant interest in the use of such extracorporeal therapies for renal support and possibly for the therapy of sepsis. Ongoing research and prospective studies will further elucidate the role of such therapies in this setting.

Citing Articles

Hemofiltration in Patients with Severe Acute Pancreatitis (Review).

Boyarinov G, Zubeyev P, Mokrov K, Voyennov O Sovrem Tekhnologii Med. 2021; 12(1):105-121.

PMID: 34513045 PMC: 8353697. DOI: 10.17691/stm2020.12.1.14.

Posthepatectomy liver failure.

Ocak I, Topaloglu S, Acarli K Turk J Med Sci. 2020; 50(6):1491-1503.

PMID: 32718126 PMC: 7605090. DOI: 10.3906/sag-2006-31.

A multi-center cross-sectional study on blood purification among adult patients in intensive care unit in China: a study protocol.

Gao Y, Qi Z, Liu R, Liu H, Han Q, Zhang X Chin Med J (Engl). 2019; 132(10):1208-1211.

PMID: 30882465 PMC: 6511420. DOI: 10.1097/CM9.0000000000000180.

Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes.

Murugan R, Wen X, Keener C, Pike F, Palevsky P, Unruh M Clin J Am Soc Nephrol. 2015; 10(6):926-33.

PMID: 25862777 PMC: 4455205. DOI: 10.2215/CJN.04560514.

Management of septic shock.

Lodha R, Oleti T, Kabra S Indian J Pediatr. 2011; 78(6):726-33.

PMID: 21541646 DOI: 10.1007/s12098-011-0415-z.

References

DIntini V, Bordoni V, Bolgan I, Bonello M, Brendolan A, Crepaldi C . Monocyte apoptosis in uremia is normalized with continuous blood purification modalities. Blood Purif. 2004; 22(1):9-12. DOI: 10.1159/000074918. View

Ronco C, Brendolan A, DIntini V, Ricci Z, Wratten M, Bellomo R . Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif. 2003; 21(6):409-16. DOI: 10.1159/000073444. View

Ronco C . Critical care nephrology: the journey has begun. Int J Artif Organs. 2004; 27(5):349-51. DOI: 10.1177/039139880402700502. View

Brendolan A, DIntini V, Ricci Z, Bonello M, Ratanarat R, Salvatori G . Pulse high volume hemofiltration. Int J Artif Organs. 2004; 27(5):398-403. DOI: 10.1177/039139880402700508. View

Lauer A, Saccaggi A, Ronco C, Belledonne M, GLABMAN S, Bosch J . Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics. Ann Intern Med. 1983; 99(4):455-60. DOI: 10.7326/0003-4819-99-4-455. View

Mariano F, Fonsato V, Lanfranco G, Pohlmeier R, Ronco C, Triolo G . Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies. Nephrol Dial Transplant. 2005; 20(6):1116-26. DOI: 10.1093/ndt/gfh776. View

Ronco C . The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis. Crit Care. 2005; 9(6):631-3. PMC: 1414022. DOI: 10.1186/cc3890. View

Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S . Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med. 2005; 32(1):80-6. DOI: 10.1007/s00134-005-2815-x. View

Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P . Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000; 356(9223):26-30. DOI: 10.1016/S0140-6736(00)02430-2. View

10.

Mariano F, Tetta C, Guida G, Triolo G, Camussi G . Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int. 2001; 60(4):1598-605. DOI: 10.1046/j.1523-1755.2001.00974.x. View

11.

Reiter K, Bellomo R, Ronco C, Kellum J . Pro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock?. Crit Care. 2002; 6(1):18-21. PMC: 137392. DOI: 10.1186/cc1448. View

12.

Reiter K, DIntini V, Bordoni V, Baldwin I, Bellomo R, Tetta C . High-volume hemofiltration in sepsis. Theoretical basis and practical application. Nephron. 2002; 92(2):251-8. DOI: 10.1159/000063325. View

13.

Ronco C, Bellomo R . Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs. 2002; 25(8):733-47. DOI: 10.1177/039139880202500801. View

14.

Ronco C, Tetta C, Mariano F, Wratten M, Bonello M, Bordoni V . Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003; 27(9):792-801. DOI: 10.1046/j.1525-1594.2003.07289.x. View

15.

Ronco C, Bonello M, Bordoni V, Ricci Z, DIntini V, Bellomo R . Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 2004; 22(1):164-74. DOI: 10.1159/000074937. View